Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy.
Teuta Zoto MustafayevMenekse TurnaYasemin BolukbasiEvrim TezcanliYildiz GuneyFazilet Oner DincbasBeste Melek AtasoyGamze UgurluerHale Basak CaglarBanu AtalarEnis OzyarPublished in: BMC cancer (2024)
The use of BV caused clinical response rate of 77.5% and a good radiological response in corticosteroid unresponsive patients. The role of BV should be further investigated in prospective studies.
Keyphrases
- end stage renal disease
- ejection fraction
- lipopolysaccharide induced
- newly diagnosed
- early stage
- lps induced
- peritoneal dialysis
- radiation therapy
- prognostic factors
- squamous cell carcinoma
- white matter
- resting state
- small cell lung cancer
- patient reported outcomes
- mass spectrometry
- high resolution
- single molecule
- functional connectivity
- metastatic colorectal cancer
- subarachnoid hemorrhage
- combination therapy
- cerebral ischemia